Cargando…

House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up

BACKGROUND: Maintenance doses for allergen immunotherapy (AIT) have been recommended for at least 3 years but little data on long‐term efficacy is available depending on AIT duration. To show sustained efficacy 10 years after completion of treatment with depigmented‐polymerized house dust mite (dpg‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez‐Plata, Elena, Callero Viera, Ariel, Ruiz‐Garcia, Monica, Gomez‐Cardenosa, Aida, Nieto, Eva, García‐Robaina, Jose Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571497/ https://www.ncbi.nlm.nih.gov/pubmed/37904678 http://dx.doi.org/10.1002/iid3.1004

Ejemplares similares

Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain
por: García Robaina, José Carlos, et al.
Publicado: (2016)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
por: Muntean, Ioana Adriana, et al.
Publicado: (2020)

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children
por: Brzozowska, A., et al.
Publicado: (2022)

Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
por: Rattanamanee, Tipyapa, et al.
Publicado: (2022)

Prevalence and Clinical Characteristics of Local Allergic Rhinitis to House Dust Mites
por: Jung, Chang-Gyu, et al.
Publicado: (2017)

Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis
por: Ma, Yun, et al.
Publicado: (2020)

A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018)

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis
por: Okamoto, Y., et al.
Publicado: (2016)

TSLP receptor is not essential for house dust mite-induced allergic rhinitis in mice
por: Nakanishi, Wakako, et al.
Publicado: (2016)

Precision Medicine in House Dust Mite-Driven Allergic Asthma
por: Eguiluz-Gracia, Ibon, et al.
Publicado: (2020)

Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model
por: Kim, Soo Whan
Publicado: (2015)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite
por: Duan, Su, et al.
Publicado: (2021)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
por: Leger, Damien, et al.
Publicado: (2017)

IL-25 Could Be Involved in the Development of Allergic Rhinitis Sensitized to House Dust Mite
por: Kim, Dae Woo, et al.
Publicado: (2017)

Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021)

Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis
por: Kim, Sae-Hoon, et al.
Publicado: (2018)

Brain activation after nasal histamine provocation in house dust mite allergic rhinitis patients
por: Callebaut, Ina, et al.
Publicado: (2020)

Exposure to House Dust Mite Allergen and Endotoxin in Early Life and Sensitization and Allergic Rhinitis: The JECS
por: Kojima, Reiji, et al.
Publicado: (2022)

Asthma, Airway Symptoms and Rhinitis in Office Workers in Malaysia: Associations with House Dust Mite (HDM) Allergy, Cat Allergy and Levels of House Dust Mite Allergens in Office Dust
por: Lim, Fang Lee, et al.
Publicado: (2015)

Efficacy analysis of three-year subcutaneous SQ-standardized specific immunotherapy in house dust mite-allergic children with asthma
por: HUI, YU, et al.
Publicado: (2014)

Asthma and allergic rhinitis risk depends on house dust mite specific IgE levels in PARIS birth cohort children()
por: Gabet, Stephan, et al.
Publicado: (2019)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
por: Xie, Shaobing, et al.
Publicado: (2022)

House dust mite (HDM) and storage mite (SM) molecular sensitisation profiles and association with clinical outcomes in allergic asthma and rhinitis: protocol for a systematic review
por: Matos-Semedo, Filipa, et al.
Publicado: (2021)

House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022)

Regulation of Constitutive Neutrophil Apoptosis Due to House Dust Mite Allergen in Normal and Allergic Rhinitis Subjects
por: Kim, Eun Hye, et al.
Publicado: (2014)

IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis
por: Nakanishi, Wakako, et al.
Publicado: (2013)

Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis
por: Chen, Yang, et al.
Publicado: (2020)

Strain-Specific Differences in House Dust Mite (Dermatophagoides farinae)-Induced Mouse Models of Allergic Rhinitis
por: Lee, Ki-Il, et al.
Publicado: (2020)

Validated allergen exposure chamber is plausible tool for the assessment of house dust mite‐triggered allergic rhinitis
por: Zemelka‐Wiacek, Magdalena, et al.
Publicado: (2022)

Allergic rhinitis behavioral changes after Indonesian house dust mites allergenic extract administration as immunotherapy
por: Pratama, Yusuf Alif, et al.
Publicado: (2023)

Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite
por: Compalati, Enrico, et al.
Publicado: (2015)

Shrimp sensitization in house dust mite allergic patients
por: Ukleja-Sokołowska, Natalia, et al.
Publicado: (2020)

Altered Sphingolipid Metabolism Is Associated With Asthma Phenotype in House Dust Mite-Allergic Patients
por: Kowal, Krzysztof, et al.
Publicado: (2019)

Insights Into Mucosal Innate Immune Responses in House Dust Mite-Mediated Allergic Asthma
por: Abu Khweek, Arwa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g260q3ga378drp5fjd9t2khjgd